| Ansøgningsnr. og dato | 17841107.0 (espacenet) (Federated) (European Patent Register), 20170818 | | Patent/reg.nr. og dato | DK/EP 3500299, 20231213 | | Tilgængelighedsdato | 20190626 | | Prioritetsnr. og dato | WO PCT/CN2016/096082, 20160819 | | EP publ. nr. og dato |
EP 3500299 20190626 | | Løbedag | | | Ansøger/indehaver | BeiGene Switzerland GmbH, Aeschengraben 27
4051 Basel, CH | | Ansøgers ref. nr. | V470057DK00 | | Opfinder | SONG, Jing, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
LI, Kang, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
ZHANG, Tong, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
WANG, Lai, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
LUO, Lusong, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
WEI, Min, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
HU, Nan, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
WANG, Zhiwei, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN,
GUO, Yunhang, No.30 Science Park Road
Zhongguancun Life Science Park
Changping
Beijing 102206, CN | | Fuldmægtig | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/4162 (2006.01) , A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Titel/benævnelse | Kombination af zanubrutinib med et anti-CD20- eller et anti-PD-1-antistof til anvendelse i behandling af cancer | | Internationalt ansøgningsnr. | CN2017098023 | | Internationalt publ. nr. | WO2018033135 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
